Abstract
Diagnosis of a malignancy during pregnancy presents a dilemma regarding the work-up and treatment of the patient. This report presents a 42-year-old woman on her 23rd week of pregnancy with multiple enlarging fungating violaceous skin masses. Biopsy of the dominant mass revealed anaplastic large cell lymphoma. Due to the progressive enlargement and increase in number of the masses, the patient was given two cycles of chemotherapy (doxorubicin, vincristine, cyclophosphamide and prednisone) before delivering a live baby boy via spontaneous vaginal delivery, Apgar 9.9, at 37 4/7 weeks. After delivery, she completed four more cycles of treatment. A full-body positron emission tomography scan done 2 months after the last chemotherapy showed no evidence of disease. The patient is doing well with no evidence of disease 9 months after treatment. Her baby is thriving and has no gross deformities and no developmental delays.
Reference24 articles.
1. The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells;Stein;Blood,1985
2. The biology and management of systemic anaplastic large cell lymphoma;Hapgood;Blood,2015
3. Goldman N, Lee M, Priore G, 2015. Management of the obstetric patient with malignancy [Internet]. The Global Library of Women’s Medicine https://www.glowm.com/section_view/heading/Management%20of%20the%20Obstetric%20Patient%20With%20Malignancy/item/193#r1ippincott William & Wilkins (cited 20 Feb 2018).
4. Cancer in pregnancy: a review of the literature. Part I;Antonelli;Obstet Gynecol Surv,1996
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献